Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Dr Reddys Labs inks pact with Henlius for commercialization of multiple myeloma injection HLX15 in US, Europe

Dr Reddy's Labs executes security subscription, shareholders' agreement with TEQ Green Power XI Private Limited, its affiliates

Ruchika Sharma17 July 2023 12:30 PM IST

Telangana: Dr. Reddy’s Laboratories Limited has announced that the Company has entered into a Security Subscription and Shareholders’ Agreement for...

Aurobindo Pharma arm API facility gets 3 observations from USFDA

Aurobindo Pharma gets USFDA EIR for Anakapalli facility

Ruchika Sharma17 July 2023 11:29 AM IST

Hyderabad: Aurobindo Pharma has recently announced that the company has received Establishment Inspection Report from the U.S. Food and Drug...

Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE Mark

Roche announces positive phase III results for Ocrevus twice a year, 10-minute subcutaneous injection in multiple sclerosis patients

Ruchika Sharma16 July 2023 2:30 PM IST

Basel: Roche has announced that the Phase III OCARINA II trial evaluating OCREVUS (ocrelizumab) as a twice a year 10-minute subcutaneous injection met...

AstraZeneca, Daiichi Sankyo gets Chinese nod for Enhertu as first HER2-directed therapy for patients with HER2-low metastatic breast cancer

Ruchika Sharma16 July 2023 1:00 PM IST

Enhertu is a HER2-directed ADC.

Bristol Myers Squibb Breyanzi approved by USFDA for adults with Marginal Zone Lymphoma

Bristol Myers Squibb, Evotec enter licence agreement within neuroscience partnership

Ruchika Sharma16 July 2023 11:30 AM IST

Evotec receives a $ 40 m payment and is eligible to earn performance milestone payments, as well as tiered royalties up to low double-digit...

Gilead Sciences gets USFDA nod for new Biktarvy indication

Gilead partners with CHAI, Penta to improve treatment, adherence rates among children with HIV in low, middle income countries

Ruchika Sharma16 July 2023 10:00 AM IST

Foster City: Gilead Sciences, Inc. has announced two public-private partnerships. The first will accelerate the development of an investigational...

Gilead Sciences gets USFDA nod for Veklury for COVID treatment in patients with severe renal impairment, including those on dialysis

Ruchika Sharma15 July 2023 3:30 PM IST

The updated prescribing information for Veklury does not require dose adjustments for renally-impaired patients and removes the requirement for eGFR...

New drugs bill to regulate imports, manufacturing of medicines to be considered by Indian lawmakers

Ruchika Sharma15 July 2023 2:30 PM IST

New Delhi: India's lawmakers will consider a new drugs bill next week on rules for importing, manufacturing and selling medicines, according to a...

Eli Lilly to acquire Versanis for USD 1.925 billion

Ruchika Sharma15 July 2023 1:00 PM IST

Indianapolis: Eli Lilly and Company and Versanis Bio have announced a definitive agreement for Lilly to acquire Versanis, a private...

Lupin secures SBTi validation for emission reduction targets

Lupin bags USFDA nod for Chlorpromazine Hydrochloride Tablets

Ruchika Sharma15 July 2023 11:45 AM IST

Mumbai: Global pharma major Lupin Limited has announced that its wholly-owned subsidiary, Lupin Inc., based in Somerset, New Jersey, has received...

Intas Pharma marketing authorization application for proposed biosimilar of Stelara accepted by EMA

Ruchika Sharma15 July 2023 11:00 AM IST

DMB-3115 is a proposed biosimilar to Stelara which is a blockbuster drug developed by Janssen Biotech Inc. for plaque psoriasis, psoriatic arthritis,...

Roivant Sciences in talks to sell bowel disease drug to Roche in over USD 7 bilion deal: Report

Ruchika Sharma15 July 2023 10:00 AM IST

RVT-3101 showed improvement in inflammation and ulcers in colon, when compared to placebo, in a mid-stage study in June.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok